companydata.dkcompanydata.dk

Merck Life Science A/S: Financial statements 2019

CVR: 20830131

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 53,447,114 and a net result of DKK 27,387,479 compared with DKK 16,709,359 the year before. That is an increase of 98.7% compared with the year before. Equity in the 2019 report amounted to DKK 135,690,861. The solvency ratio was 74.7%. The company had 9 employees in the financial year.

Gross Profit
DKK 53,447,114
Profit/Loss
DKK 27,387,479
Equity
DKK 135,690,861
Total Assets
DKK 181,671,113
Employees
9

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-53.4M27.4M135.7M9
2018-26.9M16.7M67.1M14
2017-21.3M8.6M50.4M16
2016-20.3M6.2M41.7M17
2015-34.3M7.4M35.5M17

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

SIGMA-ALDRICH DENMARK A/S changes name to Merck Life Science A/SNov 4, 2019

On November 4, 2019, the company changed its name from SIGMA-ALDRICH DENMARK A/S to Merck Life Science A/S.

Enrique Álvarez Fernández joins the board of Merck Life Science A/SJun 1, 2019

As of June 1, 2019, Enrique Álvarez Fernández has joined the board of directors of Merck Life Science A/S.

Renée Christine Tunold leaves the board of Merck Life Science A/SJun 1, 2019

As of June 1, 2019, Renée Christine Tunold has left the board of directors of Merck Life Science A/S.

Enrique Álvarez Fernández joins Merck Life Science A/S as adm. dir.Jun 1, 2019

As of June 1, 2019, Enrique Álvarez Fernández is registered as adm. dir. of Merck Life Science A/S.

Tiina Marjatta Puhakka steps down as adm. dir. of Merck Life Science A/SJun 1, 2019

As of June 1, 2019, Tiina Marjatta Puhakka has stepped down as adm. dir. of Merck Life Science A/S.

Merck Life Science A/S: The 2018 annual report is outApr 25, 2019

Merck Life Science A/S has published its annual report for 2018. Gross profit came to DKK 26,897,123, and the net result was DKK 16,709,359.

SIGMA-ALDRICH DENMARK ApS changes name to SIGMA-ALDRICH DENMARK A/SApr 10, 2019

On April 10, 2019, the company changed its name from SIGMA-ALDRICH DENMARK ApS to SIGMA-ALDRICH DENMARK A/S.

Jeanette Sandholmen joins the board of Merck Life Science A/SApr 9, 2019

As of April 9, 2019, Jeanette Sandholmen has joined the board of directors of Merck Life Science A/S.

Tiina Marjatta Puhakka joins the board of Merck Life Science A/SApr 9, 2019

As of April 9, 2019, Tiina Marjatta Puhakka has joined the board of directors of Merck Life Science A/S.

Jeanette Sandholmen leaves the board of Merck Life Science A/SApr 8, 2019

As of April 8, 2019, Jeanette Sandholmen has left the board of directors of Merck Life Science A/S.

About Merck Life Science A/S

Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.

Source: annual report 2025, Danish Business Authority